Exploring the role of KCNN2 in dominant neurodevelopmental movement disorders


  • KCNN2 genetic variants were associated with novel dominant channelopathies characterized by developmental delay, intellectual disability and movement disorders.

Why this matters

    An association between mutations of the KCNN2-encoded small conductance calcium-activated potassium channel 2 (SK2) and neurodevelopmental movement disorders has only been definitively demonstrated in rodent models.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.